LM2I leads to CAD ubiquitination and liver cancer suppression through activation of ASS1.
Study designOther primary literature
SubjectHuman & animal
Record checks
- Study design
- Other primary literature
- Subject
- Human & animal
- Publication year
- 2025
- Source
- doi.org
- Abstract display
- Not reproduced here
- Publication status
- Active
- Status checked
- 17 Aug 2026
- Collected
- 13 Aug 2026
- Freshness
- Current
- Review stage
- Automated
- Record status
- Published
Abstract
cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。
MeSH
DOI 10.3724/abbs.2025083
PMID 40448443
View source →